Theatre 5: Rehab
Tuesday 26th March
Wednesday 27th March
11.00 - 11.30
Functional electrical stimulation (FES) systems are capable of producing measurable mobility improvements for patients with foot drop and/or knee control issues caused by an upper motor neuron disease or injury such as: Stroke, Multiple Sclerosis, Cerebral Palsy, Incomplete Spinal Cord Injury, Traumatic Brain Injury.
11.45 - 12.15
Reflections on the challenges of seating solutions for Neurological clients with complex postures and their impact on function.
The seminar will include case studies of neurological clients with complex postural presentations. Clinical challenges will be identified when considering the neurological presentation of the client, rehabilitation needs, accessibility of wheeled seating solutions and the impact these seating solutions can have on both client and care-givers
12.30 - 13.00
Dr Steven Ariss
Evidencing the ‘Value’ of a Neurorehabilitation – How to present outcomes data to support a service.
This session will explore how teams/services should be analysing and interpreting outcomes data and then presenting it to inform ways to improve service standards. The main outcome from this session will be to improve confidence that implementing outcome measurement will provide the information you are looking for to support your service. The session will use the extensive experience there has now been with the Therapy Outcome Measure (TOMs).
13.15 - 13.45
Transitioning from NHS services can leave people feeling isolated and concerns clinicians faced with discharging patients at the “end of the pathway”. QEF work with local health partners to develop the Surrey Stroke Recovery Programme to bridge the gap for stroke survivors coming to the end of NHS commissioned stroke rehabilitation. This seminar offers a 3 rd sector perspective on achieving self-management.
14.00 - 14.30
We will present two different technologies to improve and monitor the progress of neurological patients. One focuses on activation of the withdrawal reflex in the leg of stroke victims, where a dedicated stimulation device improves the training efficiency and the long-term outcome of gait training for the patients. The other is a device for objective measurement of active and passive muscle/joint stiffness and monitoring of developing spasticity in neurological patients.
14.45 - 15.15
Lynn Vale and Vicky Knight
In this seminar you will learn the theory to apply NMES for a variety of different impairments in the neurological patient, using both single and multichannel applications. The seminar will cover both complex clinical presentation and also addressing applications that can be applied outside the patient’s 1:1 treatment intervention so that treatment dosage and intensity may be optimised.
15.30 - 16.00
Prof. Nathan Intrator
We introduce a medical device for brain assessment and neurofeedback which can be used for screening and monitoring patients in clinical trials and for intervention optimizing. We demonstrate its relevance to medical applications related to neurodegenerative disorders and cognitive decline.